Relmada Therapeutics shares owned by Goldman Sachs Group
Quarter-by-quarter ownership of Relmada Therapeutics (RLMD) shares owned by Goldman Sachs Group
from 13F filings
Historical chart of Goldman Sachs Group investment in Relmada Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Relmada Therapeutics held by Goldman Sachs Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Relmada Therapeutics by Goldman Sachs Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-03-31 | $550k | 118k | 4.65 |
| 2023-09-30 | $39k | 13k | 3.00 |
| 2023-06-30 | $399k | 162k | 2.46 |
| 2023-03-31 | $452k | 200k | 2.26 |
| 2022-12-31 | $913k | 262k | 3.49 |
| 2022-06-30 | $3.5M | 184k | 18.99 |
| 2022-03-31 | $791k | 29k | 26.99 |
| 2021-12-31 | $1.9M | 84k | 22.53 |
| 2021-09-30 | $2.3M | 86k | 26.21 |
| 2021-03-31 | $819k | 23k | 35.19 |
| 2020-12-31 | $452k | 14k | 32.09 |
| 2019-12-31 | $211k | 5.4k | 38.98 |